about
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisPreferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experimentThe HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring.Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial.'Leaving no one behind': reflections on the design of community-based HIV prevention for migrants in Johannesburg's inner-city hostels and informal settlements.Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African womenClinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis.Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa'I heard about this study on the radio': using community radio to strengthen Good Participatory Practice in HIV prevention trials.Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.Prevalence and correlates of bacterial vaginosis in different sub-populations of women in sub-Saharan Africa: a cross-sectional study.Bidirectional links between HIV and intimate partner violence in pregnancy: implications for prevention of mother-to-child transmissionUsing HPV vaccination for promotion of an adolescent package of care: opportunity and perspectives.Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countriesA post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trialCognitive mapping: using local knowledge for planning health research.Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmissionEstimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa.Using research to influence sexual and reproductive health practice and implementation in Sub-Saharan Africa: a case-study analysisInvesting in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South AfricaA global study on the influence of neighborhood contextual factors on adolescent healthCorrelates of the molecular vaginal microbiota composition of African women.Providing comprehensive health services for young key populations: needs, barriers and gapsHow adolescents perceive their communities: a qualitative study that explores the relationship between health and the physical environmentThe significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African womenCross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships.Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial.Prevalence and determinants of adolescent pregnancy in urban disadvantaged settings across five cities.Social capital and vulnerable urban youth in five global cities.Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessmentA DNA tool for early detection of vaginal dysbiosis in African women.Rethinking HIV prevention to prepare for oral PrEP implementation for young African womenA Multi-Country Cross-Sectional Study of Vaginal Carriage of Group B Streptococci (GBS) and Escherichia coli in Resource-Poor Settings: Prevalences and Risk FactorsAcyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations.'It's not about money, it's about my health': determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South AfricaAssociations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical TrialEffect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.
P50
Q21144588-FCB3F704-DA3C-45DE-B0BC-145B739887DAQ28596813-A3D20598-1662-46AC-9F20-7CD77C11DE32Q30249204-89205355-A275-4B09-959C-7A07462DA51AQ33313869-A4799824-C263-4B67-8F6C-E825286B16B6Q33710481-C5747F4E-3675-4199-BE39-8B369F250611Q33753930-E37E5373-0B5D-4308-8BE1-9B372BEB6FC3Q33797142-E2F24AB1-5715-4381-928A-EFB93EDE717FQ33831737-22B192A6-5295-4C5D-ACD5-D2ED8232E347Q33971596-6E239427-76E7-4337-B382-876B49A75C0BQ34116294-E704567E-721A-49C9-A3DA-15AA2B0A5788Q34244796-BB93D736-8DE2-4985-A48A-BE6F258920A1Q34302658-B4FFA75E-9AAF-4F52-AD39-8E78BCAD8111Q34451568-0978D2A5-1731-4905-B4E4-28F32825B39EQ34732730-F792C3C0-B422-493C-BE31-B1048AE51AE8Q34734012-248ABB30-B219-48DB-8577-F28FD26E575AQ34792200-D01C45A1-B381-454C-8F6B-FE15BC5D8A30Q34869056-2EF8450B-DD0D-43CE-A8D2-7947E735BC29Q34920252-0E476EE4-EE01-4702-8ED2-7231AA6A29B9Q35007321-77B2C2C8-7420-4162-AF3B-911376F22319Q35062445-D10C0758-FE52-4255-902F-008E2A742B6AQ35062487-F919ABCA-2852-4F7C-B724-262651BC0C4EQ35087902-85B6068A-759A-4CDD-8E9A-B1A3BD8199C6Q35128707-31F0ED63-D102-47AF-B8A9-9FFE549FD0C9Q35131217-FD5227B6-A9B2-40D1-B061-E7A78B99238BQ35146244-BA62AB52-EF2A-48CF-B08B-3A4692EA31CAQ35154469-35062ADD-7F14-4EF7-9437-E8F2EBC371FBQ35548029-01EB17DF-7B47-4369-9F40-2CBB826E3A20Q35613315-43E50BDC-9B04-4681-A5F7-3E75BA0F26ECQ35630400-3BC9A962-1253-4034-BF5F-A0B4FEECF12CQ35680822-DDF8C629-290B-4B7F-9333-B33444F51D87Q35768147-76023928-D147-42AF-A6C9-18EE7A493576Q35794339-8580406A-FF2A-4C12-B24B-5FA5BA350FE6Q35844281-9C58BC85-3AA1-4829-BA68-31F385BFB7D3Q35875710-0CE20567-FB44-448C-91F9-A70C6F5D978DQ35904763-873BD18D-25CF-4873-85DB-5E737F80D5FBQ35941348-03251F0E-C27D-4971-A8D8-6203A921F140Q36194047-9379D5D7-A5C9-4FC5-86BD-AE28BDC857ADQ36319807-9D57F48B-71FF-45FF-A32A-EA47D2340C15Q36487827-C4077967-5046-4547-A36B-53457F1CDEAFQ36497840-E10D4E39-DEE3-4D87-AEE6-6F335675E8A1
P50
name
Sinead Delany-Moretlwe
@ast
Sinead Delany-Moretlwe
@en
Sinead Delany-Moretlwe
@es
Sinead Delany-Moretlwe
@nl
type
label
Sinead Delany-Moretlwe
@ast
Sinead Delany-Moretlwe
@en
Sinead Delany-Moretlwe
@es
Sinead Delany-Moretlwe
@nl
prefLabel
Sinead Delany-Moretlwe
@ast
Sinead Delany-Moretlwe
@en
Sinead Delany-Moretlwe
@es
Sinead Delany-Moretlwe
@nl